<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from the Lifecore
Biomedical, Inc. and Subsidiaries Consolidated Financial Statements for the nine
months ended March 31, 1996, and is qualified in its entirety by reference to 
such financial statements.
</LEGEND>
       
                             
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          JUN-30-1996
<PERIOD-START>                             JUL-01-1995
<PERIOD-END>                               MAR-31-1996
<CASH>                                       1,049,000
<SECURITIES>                                15,965,000
<RECEIVABLES>                                1,872,000
<ALLOWANCES>                                   245,000
<INVENTORY>                                  8,153,000
<CURRENT-ASSETS>                            21,854,000
<PP&E>                                      13,611,000
<DEPRECIATION>                             (5,110,000)
<TOTAL-ASSETS>                              42,303,000
<CURRENT-LIABILITIES>                        4,939,000
<BONDS>                                      7,223,000
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                       106,000
<OTHER-SE>                                  29,896,000
<TOTAL-LIABILITY-AND-EQUITY>                42,303,000
<SALES>                                      9,676,000
<TOTAL-REVENUES>                             9,676,000
<CGS>                                        6,345,000
<TOTAL-COSTS>                               13,260,000
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             622,000
<INCOME-PRETAX>                            (3,630,000)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (3,630,000)
<EPS-PRIMARY>                                    (.38)
<EPS-DILUTED>                                    (.38)